Market closed

Unity Biotechnology Inc./$UBX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Ticker

$UBX
Trading on

Industry

Biotechnology

Employees

16

UBX Metrics

BasicAdvanced
$15M
-
-$1.63
1.30
-
$15M
1.3
$1.98
$0.85
143K
1.947
1.868
-9,110.732
-11,027.805
-38.89%
-231.27%
-74.97
-74.97
-0.683
-37.77%
-46.73%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $UBX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Unity Biotechnology Inc. stock?

What is the P/E ratio for Unity Biotechnology Inc. stock?

Does Unity Biotechnology Inc. stock pay dividends?

When is the next Unity Biotechnology Inc. dividend payment date?

What is the beta indicator for Unity Biotechnology Inc.?